Jeff Yass’s NovaBridge Biosciences American Depositary Shares NBP Stock Holding History

Jeff Yass’s Portfolio NBP Stock Details NBP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-16,600	Closed	-$67K	–	12994
2022 Q3	$67K	Sell	16,600 -2,200	-12%	-$16.7K	﹤0.01%	12013
2022 Q2	$212K	Sell	18,800 -18,500	-50%	-$222K	﹤0.01%	10491
2022 Q1	$606K	Buy	37,300 +30,300	+433%	+$776K	﹤0.01%	8459
2021 Q4	$332K	Sell	7,000 -22,200	-76%	-$1.33M	﹤0.01%	10230
2021 Q3	$2.12M	Sell	29,200 -400	-1%	-$28.9K	﹤0.01%	5703
2021 Q2	$2.48M	Buy	+29,600	New	+$1.95M	﹤0.01%	5431

Other funds holding NBP

HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

ACM

AIHC Capital Management Central $104M AUM

Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return

Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

Candriam SCA Strassen, Luxembourg, Luxembourg $22.2B AUM 58.34% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Jeff Yass's NBP Position: Q2 2026 in Review

Jeff Yass increased its NovaBridge Biosciences American Depositary Shares (NBP) stake by 123% in Q2 2026, buying an estimated $32.1K and bringing the position to 28,539 shares worth $55.7K. The position accounts for ﹤0.01% of the portfolio, ranked #12791.

Jeff Yass first reported a position in NBP in Q2 2021 and has held it in 15 quarters since. The position peaked at $922K in Q2 2021. 49 funds tracked by Wall St. Rank hold NBP as of Q2 2026.

Jeff Yass held 28,539 shares of NovaBridge Biosciences American Depositary Shares worth $55.7K as of Q2 2026.
Jeff Yass bought 15,722 NovaBridge Biosciences American Depositary Shares shares in Q2 2026, an estimated $32.1K.
NovaBridge Biosciences American Depositary Shares made up ﹤0.01% of Jeff Yass's portfolio in Q2 2026, its #12791 holding.
Jeff Yass first reported a position in NovaBridge Biosciences American Depositary Shares in Q2 2021 and has held it in 15 quarters since.
Jeff Yass's NovaBridge Biosciences American Depositary Shares position peaked at $922K in Q2 2021.
49 funds tracked by Wall St. Rank held NovaBridge Biosciences American Depositary Shares as of Q2 2026.

Based on Susquehanna International Group's 13F filing for Q2 2026, filed 14 Aug 2026.